NYSE:CNC

Centene (CNC) Stock Price, News & Analysis

Centene logo
$64.48 -2.97 (-4.41%)
As of 11:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Centene Stock (NYSE:CNC)

Advanced

Key Stats

Today's Range
$63.91
▼
$68.09
50-Day Range
$60.95
▼
$76.03
52-Week Range
$31.63
▼
$78.08
Volume
1.23 million shs
Average Volume
5.65 million shs
Market Capitalization
$31.92 billion
P/E Ratio
22.12
Dividend Yield
N/A
Price Target
$75.10
Consensus Rating
Hold

Company Overview

Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace.

Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage. The company also provides services such as pharmacy benefits and care coordination.

Founded in 1984 as a nonprofit Medicaid plan in Milwaukee, Wisconsin, Centene has grown into a national health care organization. It is headquartered in St. Louis, Missouri, and operates across the United States.

AI Generated. May Contain Errors.

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

CNC MarketRank™: 
4.375256603255 of 5 stars

Centene scored higher than 88% of companies evaluated by MarketBeat, and ranked 67th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on no strong buy ratings, 9 buy ratings, 11 hold ratings, and 1 sell rating.

  • Upside Potential

    Centene has a consensus price target of $75.10, representing about 11.0% upside from its current price of $67.64.

  • Amount of Analyst Coverage

    Centene has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 5.31% in the coming year, from $5.27 to $5.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is 23.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.46.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is 23.17, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    2.13% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 2.04, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently decreased by 3.92%, indicating that investor sentiment is improving.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • News Sentiment

    Centene has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Centene this week, compared to 7 articles on an average week.
  • Search Interest

    19 people have searched for CNC on MarketBeat in the last 30 days. This is an increase of 19% compared to the previous 30 days.
  • MarketBeat Follows

    15 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 36% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,779,850.00 in company stock.

  • Percentage Held by Insiders

    0.37% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Stock News Headlines

I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
Centene (CNC) Stock Still Looks Undervalued On Its 96% Run
Centene (CNC) Could Be 4% Undervalued As Recovery Narrative Holds
Centene: Margin Repair Is Real, But The Shares Already Price It In
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $41.18 at the beginning of the year. Since then, CNC shares have increased by 64.3% and is now trading at $67.6440.

Centene Corporation (NYSE:CNC) issued its quarterly earnings results on Tuesday, October, 27th. The company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.48. The business's revenue for the quarter was up 1.9% compared to the same quarter last year.
Read the conference call transcript
.

Centene shares split on Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were distributed to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

The following companies are subsidiaries of Centene: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others.

Top institutional shareholders of Centene include State Street Corp (4.66%), Assenagon Asset Management S.A. (0.91%), Robeco Institutional Asset Management B.V. (0.67%) and Russell Investments Group Ltd. (0.53%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Christopher Koster, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include NVIDIA (NVDA), UnitedHealth Group (UNH), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU), Visa (V) and PayPal (PYPL).

Company Calendar

Last Earnings
10/27/2026
Today
11/19/2026
Fiscal Year End
12/31/2026
Next Earnings (Estimated)
2/05/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Managed Healthcare
Current Symbol
NYSE:CNC
CIK
1071739
Employees
61,100
Year Founded
1984

Price Target and Rating

High Price Target
$90.00
Low Price Target
$40.00
Potential Upside/Downside
+16.2%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
21 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.92
Trailing P/E Ratio
22.14
Forward P/E Ratio
11.64
P/E Growth
0.42
Net Income
-$6.67 billion
Net Margins
0.72%
Pretax Margin
0.94%
Return on Equity
12.15%
Return on Assets
3.28%

Debt

Debt-to-Equity Ratio
0.69
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$203.90 billion
Price / Sales
0.16
Cash Flow
$4.17 per share
Price / Cash Flow
15.48
Book Value
$45.01 per share
Price / Book
1.44

Miscellaneous

Outstanding Shares
495,068,000
Free Float
493,236,000
Market Cap
$31.99 billion
Optionable
Optionable
Beta
1.07

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:CNC) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners